Narrative review of Vitamin D status and deficiency determinants in Ghana
# Vitamin D Status in Ghana: A Systematic Review with Meta-Analysis of Prevalence, Comorbidity Signals, and Evidence Gaps
**Author:** Valentine Golden Ghanem
**Affiliation:** Ghana COCOBOD Cocoa Clinic, Accra, Ghana
**ORCID:** 0009-0002-8332-0220
**Reporting standard:** PRISMA 2020
**OSF registration:**
doi.org
**Release:** v1.1.0
## 1. What This Repository Contains
This repository supports a PRISMA 2020 systematic review with meta-analysis of vitamin D status in Ghana. The review includes 17 eligible peer-reviewed studies. VDD prevalence could be extracted from 9 independent analytic rows comprising 1,609 participants. Seven rows comprising 1,153 participants contributed descriptive mean 25(OH)D data.
The random-effects pooled VDD prevalence is **55.3%** (95% CI 35.5-75.2; I2=99.0%). The mean 25(OH)D estimate is **25.1 ng/mL** (95% CI 12.7-37.5) among rows with usable mean data.
## 2. Quantitative Synthesis Rules
The quantitative synthesis follows prespecified compatibility rules:
- Asare 2017 reports vitamin D mean values but no VDD prevalence.
- Sakyi 2022 reports RA/control 25VD means with a printed pg/mL unit and no VDD prevalence.
- Dzudzor 2023 reports chronic liver disease vitamin D as median/IQR and no VDD prevalence.
- Fondjo 2022 is treated as a median/IQR psychiatric-patient study with treatment-active VDD prevalence, not as a mean/SD row.
- Fondjo 2018 VDD prevalence is retained, but its 25(OH)D mean is converted from the source's nmol/L table rather than treated as ng/mL.
The repository therefore reports pooled estimates only where a compatible denominator, outcome definition and independent analytic row were available. Formal spatial-cluster inference and prediction modelling are outside the inferential scope of this evidence base.
## 3. Key Findings
| Metric | Value |
|---|---|
| Eligible studies | 17 |
| Eligible VDD prevalence rows | 9 |
| VDD prevalence analytic N | 1,609 |
| Random-effects VDD prevalence | 5 …